TP53 and large cell neuroendocrine carcinoma: In contrast to SCLC, LCNEC of the lung is genetically more heterogeneous, with TP53/RB1 co-inactivation only in a subset of tumors, while those lacking these alterations harbor mutations that are more frequently seen in pulmonary adenocarcinomas43,44.